Siemens Healthineers AG (SHL) Stock Forecast & Price Target

Compare

60 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SHL Analyst Ratings

Strong Buy

13 Buy

2 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Siemens

Healthineers AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SHL Stock 12 Month Forecast

Average Price Target

€60.93

▲(29.91%Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is €60.93 with a high forecast of €66.98 and a low forecast of €55.98. The average price target represents a 29.91% change from the last price of €46.90.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"44":"€44","67":"€67","49.75":"€49.8","55.5":"€55.5","61.25":"€61.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":66.98079621152715,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€66.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60.9255187746,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€60.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":55.9839490723212,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€55.98</span>\n  </div></div>","useHTML":true}}],"tickPositions":[44,49.75,55.5,61.25,67],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.79,47.42006124704055,49.0501224940811,50.68018374112165,52.3102449881622,53.94030623520275,55.5703674822433,57.20042872928385,58.8304899763244,60.460551223364945,62.0906124704055,63.72067371744605,65.3507349644866,{"y":66.98079621152715,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.79,46.95427067496923,48.11854134993846,49.28281202490769,50.44708269987692,51.61135337484615,52.775624049815384,53.939894724784615,55.104165399753846,56.26843607472308,57.43270674969231,58.59697742466154,59.76124809963077,{"y":60.9255187746,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,45.79,46.57414992864009,47.35829985728019,48.14244978592028,48.92659971456037,49.710749643200465,50.494899571840556,51.279049500480646,52.06319942912074,52.847349357760834,53.631499286400924,54.415649215041014,55.19979914368111,{"y":55.9839490723212,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":52.492,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.944,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.529,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.45,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.295,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.536,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.958,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.348,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.046,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.12,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.38,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.79,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€66.98

Average Price Target€60.93

Lowest Price Target€55.98

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

€53

Buy

13.01%

Upside

Reiterated

06/26/25

Siemens Healthineers AG's strong financial performance and positive earnings call sentiment are the most significant factors driving the score. The stock's valuation is high, but partially offset by a reasonable dividend yield. Technical analysis provides a neutral to slightly cautious outlook.

Hassan Al-WakeelBarclays

Barclays

€62→€61

Buy

30.06%

Upside

Reiterated

06/27/25

Siemens Healthineers AG (SEMHF) Gets a Buy from Barclays

Graham DoyleUBS

UBS

―

Hold

―

Reiterated

06/27/25

UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)

David AdlingtonJ.P. Morgan

J.P. Morgan

€60.5

Buy

29.00%

Upside

Reiterated

06/27/25

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Dexcom (NASDAQ: DXCM)

Julien DormoisJefferies

Jefferies

€60

Buy

27.93%

Upside

Reiterated

06/26/25

Analysts Are Bullish on These Healthcare Stocks: DBV Technologies SA - American (DBVT), Siemens Healthineers AG (SEMHF)

Veronika DubajovaCiti

Citi

€66.5→€62

Buy

32.20%

Upside

Reiterated

06/05/25

Citi Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Lisa Bedell CliveBernstein

Bernstein

€60→€59

Buy

25.80%

Upside

Reiterated

06/04/25

Bernstein Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Sam EnglandBerenberg Bank

Berenberg Bank

€57.8

Buy

23.24%

Upside

Reiterated

05/29/25

Berenberg Bank Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Nico ChenDBS

DBS

€54→€59

Buy

25.80%

Upside

Reiterated

05/15/25

Buy Rating for Siemens Healthineers AG: Strong Revenue Growth and Technological Leadership Drive Positive Outlook

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Upgraded

05/15/25

Richard FeltonGoldman Sachs

Goldman Sachs

€60→€56

Hold

19.40%

Upside

Reiterated

05/09/25

Goldman Sachs Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)

Sezgi OezenerHSBC

HSBC

€58

Buy

23.67%

Upside

Reiterated

05/08/25

HSBC Reiterates Buy Rating on Siemens Healthineers (SHL:GR) (SEMHF)HSBC analyst Sezgi Oezener reiterated a Buy rating and EUR58.00 price target on Siemens Healthineers (SHL:GR) (OTC: SEMHF).

Falko FriedrichsDeutsche Bank

Deutsche Bank

€67

Buy

42.86%

Upside

Reiterated

05/08/25

Analysts Offer Insights on Healthcare Companies: Bruker (NASDAQ: BRKR), Qiagen (NYSE: QGEN) and Siemens Healthineers AG (Other OTC: SEMHF)

Dylan Van HaaftenStifel Nicolaus

Stifel Nicolaus

€65

Buy

38.59%

Upside

Reiterated

05/07/25

Strong Imaging Performance and Strategic Management Drive Positive Outlook for Siemens Healthineers AG

Oliver ReinbergKepler Capital

Kepler Capital

€65

Buy

38.59%

Upside

Reiterated

05/07/25

Siemens Healthineers AG (SEMHF) Gets a Buy from Kepler Capital

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

€53

Buy

13.01%

Upside

Reiterated

06/26/25

Hassan Al-WakeelBarclays

Barclays

€62→€61

Buy

30.06%

Upside

Reiterated

06/27/25

Siemens Healthineers AG (SEMHF) Gets a Buy from Barclays

Graham DoyleUBS

UBS

―

Hold

―

Reiterated

06/27/25

UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)

David AdlingtonJ.P. Morgan

J.P. Morgan

€60.5

Buy

29.00%

Upside

Reiterated

06/27/25

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Dexcom (NASDAQ: DXCM)

Julien DormoisJefferies

Jefferies

€60

Buy

27.93%

Upside

Reiterated

06/26/25

Analysts Are Bullish on These Healthcare Stocks: DBV Technologies SA - American (DBVT), Siemens Healthineers AG (SEMHF)

Veronika DubajovaCiti

Citi

€66.5→€62

Buy

32.20%

Upside

Reiterated

06/05/25

Citi Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Lisa Bedell CliveBernstein

Bernstein

€60→€59

Buy

25.80%

Upside

Reiterated

06/04/25

Bernstein Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Sam EnglandBerenberg Bank

Berenberg Bank

€57.8

Buy

23.24%

Upside

Reiterated

05/29/25

Berenberg Bank Sticks to Their Buy Rating for Siemens Healthineers AG (SEMHF)

Nico ChenDBS

DBS

€54→€59

Buy

25.80%

Upside

Reiterated

05/15/25

Buy Rating for Siemens Healthineers AG: Strong Revenue Growth and Technological Leadership Drive Positive Outlook

Unknown AnalystDZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Upgraded

05/15/25

Richard FeltonGoldman Sachs

Goldman Sachs

€60→€56

Hold

19.40%

Upside

Reiterated

05/09/25

Goldman Sachs Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)

Sezgi OezenerHSBC

HSBC

€58

Buy

23.67%

Upside

Reiterated

05/08/25

HSBC Reiterates Buy Rating on Siemens Healthineers (SHL:GR) (SEMHF)HSBC analyst Sezgi Oezener reiterated a Buy rating and EUR58.00 price target on Siemens Healthineers (SHL:GR) (OTC: SEMHF).

Falko FriedrichsDeutsche Bank

Deutsche Bank

€67

Buy

42.86%

Upside

Reiterated

05/08/25

Analysts Offer Insights on Healthcare Companies: Bruker (NASDAQ: BRKR), Qiagen (NYSE: QGEN) and Siemens Healthineers AG (Other OTC: SEMHF)

Dylan Van HaaftenStifel Nicolaus

Stifel Nicolaus

€65

Buy

38.59%

Upside

Reiterated

05/07/25

Strong Imaging Performance and Strategic Management Drive Positive Outlook for Siemens Healthineers AG

Oliver ReinbergKepler Capital

Kepler Capital

€65

Buy

38.59%

Upside

Reiterated

05/07/25

Siemens Healthineers AG (SEMHF) Gets a Buy from Kepler Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

1 Month

xxx

Success Rate

10/17 ratings generated profit

Average Return

+1.78%

reiterated a xxx

rating 5 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 58.82% of your transactions generating a profit, with an average return of +1.78% per trade.

3 Months

xxx

Success Rate

16/27 ratings generated profit

Average Return

+3.24%

reiterated a xxx

rating 27 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 59.26% of your transactions generating a profit, with an average return of +3.24% per trade.

1 Year

Odysseas ManesiotisExane BNP Paribas

Success Rate

11/18 ratings generated profit

Average Return

+2.75%

reiterated a buy rating 9 months ago

Copying Odysseas Manesiotis's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +2.75% per trade.

2 Years

xxx

Success Rate

19/26 ratings generated profit

Average Return

+4.90%

reiterated a xxx

rating 4 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 73.08% of your transactions generating a profit, with an average return of +4.90% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHL Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SHL has received 21 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. SHL average Analyst price target in the past 3 months is 60.93.

Each month's total comprises the sum of three months' worth of ratings.

SHL Financial Forecast

SHL Earnings Forecast

Next quarter’s earnings estimate for SHL is €0.54 with a range of €0.51 to €0.58. The previous quarter’s EPS was €0.56. SHL beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.17% of the time in the same period. In the last calendar year SHL has Outperformed its overall industry.

SHL Sales Forecast

Next quarter’s sales forecast for SHL is €5.67B with a range of €5.60B to €5.82B. The previous quarter’s sales results were €5.91B. SHL beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.50% of the time in the same period. In the last calendar year SHL has Outperformed its overall industry.

SHL Stock Forecast FAQ

What is DE:SHL’s average 12-month price target, according to analysts?

Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is 60.93.

What is DE:SHL’s upside potential, based on the analysts’ average price target?

Siemens Healthineers AG has 29.91% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Siemens Healthineers AG a Buy, Sell or Hold?

Siemens Healthineers AG has a consensus rating of Strong Buy, which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.

What is Siemens Healthineers AG’s share price target?

The average share price target for Siemens Healthineers AG is 60.93. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €66.98 ,and the lowest forecast is €55.98. The average share price target represents 29.91% Increase from the current price of €46.9.

What do analysts say about Siemens Healthineers AG?

Siemens Healthineers AG’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of Siemens Healthineers AG?

To buy shares of DE:SHL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Siemens Healthineers AG (SHL) Stock Forecast & Price Target

SHL Analyst Ratings

SHL Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Siemens Healthineers AG

SHL Analyst Recommendation Trends

SHL Financial Forecast

SHL Earnings Forecast

SHL Sales Forecast

SHL Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts